Baloxavir Marboxil Single-dose Treatment in Influenza-infected Children: A Randomized, Double-blind, Active Controlled Phase 3 Safety and Efficacy Trial (miniSTONE-2)

Baloxavir marboxil (baloxavir) is a novel, cap-dependent endonuclease inhibitor that has previously demonstrated efficacy in the treatment of influenza in adults and adolescents. We assessed the safety and efficacy of baloxavir in otherwise healthy children with acute influenza. METHODS: MiniSTONE-2...

Descripción completa

Detalles Bibliográficos
Autores principales: Baker, Jeffrey, Block, Stanley L., Matharu, Balpreet, Burleigh Macutkiewicz, Laura, Wildum, Steffen, Dimonaco, Sophie, Collinson, Neil, Clinch, Barry, Piedra, Pedro A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Antimicrobial Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360097/
https://www.ncbi.nlm.nih.gov/pubmed/32516282
http://dx.doi.org/10.1097/INF.0000000000002747

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360097/
https://www.ncbi.nlm.nih.gov/pubmed/32516282
http://dx.doi.org/10.1097/INF.0000000000002747

Ejemplares similares